Alerts will be sent to your verified email
Verify EmailAMRAPLIN
Amrapali Industries
|
Rama Vision
|
Biogen Pharmachem
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
2.68 % | 6.61 % | 0.21 % |
5yr average Equity Multiplier
|
5.43 | 1.69 | 1.01 |
5yr Average Asset Turnover Ratio
|
152.48 | 1.86 | 0.02 |
5yr Avg Net Profit Margin
|
0.0 | 1.98 % | -19.83 % |
Price to Book
|
2.42 | 2.63 | 0.88 |
P/E
|
45.12 | 29.95 | 66.97 |
5yr Avg Cash Conversion Cycle
|
0.2 Days | 69.81 Days | 0.0 |
Inventory Days
|
0.28 Days | 77.95 Days | 0.0 |
Days Receivable
|
0.0 | 19.66 Days | 0.0 |
Days Payable
|
0.3 Days | 6.81 Days | 1109.22 Days |
5yr Average Interest Coverage Ratio
|
1.17 | 4.22 | 902.8 |
5yr Avg ROCE
|
21.59 % | 11.41 % | 0.21 % |
5yr Avg Operating Profit Margin
|
0.02 % | 4.78 % | -19.88 % |
5 yr average Debt to Equity
|
2.08 | 0.43 | 0.0 |
5yr CAGR Net Profit
|
14.37 % | 143.01 % | n/a |
5yr Average Return on Assets
|
0.61 % | 3.69 % | 0.21 % |
Shareholdings
|
|||
Promoter Holding
|
73.43 % | 54.22 % | 0.0 |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 1.84 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Amrapali Industries
|
Rama Vision
|
Biogen Pharmachem
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|